Invasive yeast infections other than Candida spp. in acute leukaemia

Journal of Hospital Infection

Volumn 41, Issue 3, 1999, Pages 181-194

  Krcmery, V ^a,c   Krupova, I ^a   Denning, D W ^b  

^a TRNAVA UNIVERSITY   (Slovakia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Heydukova 10   (Slovakia)

Author keywords

Leukaemia; Non Candida spp.; Yeasts

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIFUNGAL AGENT; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NETILMICIN; OFLOXACIN; PREDNISONE; QUINOLONE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANDIDA; CATHETER INFECTION; CRYPTOCOCCUS; EUROPE; FUNGUS IDENTIFICATION; HANSENULA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MALASSEZIA FURFUR; MORTALITY; MYCOSIS; NEUTROPENIA; NONHUMAN; RHODOTORULA; RISK FACTOR; SACCHAROMYCES CEREVISIAE; SLOVAKIA; TRICHOSPORON; UNITED STATES; YEAST;

EID: 0033050504     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(99)90015-4     Document Type: Review

References (101)

1. Jarvis W. Epidemiology of Nosocomial Fungal Infections with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-1530
2. Morrison T. Fungal infections in bone marrow transplant recipients. Am J Med 1994; 86: 1183-1189
3. Lecciones J, Lee J, Navano E, Witebsky G, Marshall D, Steinberg S, Pizzo P, Walsh T. Vascular catheter associated fungaemia in patients with cancer. Clin Infect Dis 1992; 14: 875-883
4. Kramer DG, Bostio GD, Perri MB, Band JD. Fungemia in a community hospital. Clin Infect Dis 1996; 21: S1, 100-101
5. Krčméry V jr, Špánik S, Trupl J, Kunová A. Fungaemia in cancer patients: analysis of 101 episodes. Acta chemoth 1997; 6: 133-142
6. Viscoli C, Martino P, Marinus A, Meunier F, Krčméry V jr. and the EORTC, IFICG: Invasive fungal infections cooperative group: A surveillance study on fungemia in cancer patients in Europe. Abstracts. 7-th ECCMID, Vienna, 28.3-2.4. 1995, Abstract No 44 (p.9)
7. Krčméry V jr, Špánik S S, Trupl J. Breakthrough fungaemia in cancer patients. J Antimicrob Chemoth (in press)
8. Berengner J, Fernandez V, Sanchez R, Bouza E. In vitro activity of amphotericin B, 5-FC and fluconazole against yeast causing blood-stream infections. Eur J Clin Microbiol Infect Dis 1995; 14: 363-366
9. EPIC Study group: European prevalence of infections in intensive care units. Int Care Med 1993; 39: 144-155
10. Bech-Sague C, and the National Nosocomial Infection Surveillance (NNIS) Study group: Secular trends in the epidemiology of nosocomial fungal infections in United States 1980-1990. J Inf Dis 1993; 167: 1247-1251
11. Kiehn T, Gorey E, Brown A, Edwards R. Sepsis due to Rhodotorula rubra related to the use of indwendling catheters. Clin Infect Dis 1992; 14: 841-846
12. Bert SL. Malassezia furfur fungaemia in patients without usual risk factors. Clin Infect Dis 1992; 14:620-621
13. Anaissie E, Bodey G. Trichosporonosis - meeting the challenge. Eur J Clin Microbiol Infect Dis 1991; 10: 711-713
14. Martino P, Venditti M, Micozzi A, Morace G, Rolinelli L. Blastoschizomyces capitatus. An emerging cause of invasive fungal infections in leukaemia patients. Rev Infect Dis 1990; 12: 570-572
15. Walsh T, Trichosporonosis. Inf Dis Clin N Amer 1989; 3: 43-51
16. Kunová A, Godai J, Šufliarsky J, Špánik S, Kollár T, Krčméry Vjr. Fatal Trichosporon pullulans breakthrough fungaemia in cancer patients. Infection 1996; 24: 1-3
17. Kunová A, Sorkovská D, Šufliarsky J, Hel'pianska L, Krčméry V jr. Report of catheter -associated Trichosporon pullulans breakthrough fungaemia in a cancer patients. Eur J Clin Microbiol Inf Dis 1995; 14: 729-723
18. Baird DR, Harris M, Menon R, Stoddart RW. Systemic infection with Trichosporon capitatum in two patients with acute leukemia. Eur J Clin Microb Inf Dis 1985; 4: 62-64
19. Walsh TJ, Newman KR, Moody M, Wharton RC, Wade J. Trichosporonosis in patients with neoplastic disease. Medicine (Baltimore): 1986; 65: 268-279
20. Kobayashi M, Matsuoka T, Taguchi H, Moriki T, Enzan H, Hara H, Miyoshi I. Trichosporon beigelii pneumonia in a patient with malignant histiocytosis. Jpn Journ Clin Oncol 1986; 16: 167-174
21. Bhansali S, Karanes C, Palutke V, Crane L, Kiel R, Ratanatharathorn V. Successful treatment of disseminated Trichosporon beigelii (cutaneum). Infection with associated splenic involvement. Cancer 1986; 58: 1630-1632
22. Manabe T, Moriya T, Shirabe T, Takemoto Y. Disseminated Trichosporon beigelii infection in a patient with malignant histiocytosis. Acta Pathol Jpn 1986; 36: 1241-1250
23. Leblond V, Saint-Jean O, Datry A et al. Systemic infections with Trichosporon beigelii (cutaneum). Report of three new cases. Cancer 1986; 58: 2399-2405
24. Moy J, Hsu KC, Rolston K, Hopfer RL, Luna M, Bodey GP. Trichosporon beigelii infection: a review. Rev Infect Dis 1986; 8: 959-967
25. Shimazu K, Shido T, Kimura K et al. A case of systemic Trichosporon infection associated with acute lymphocytic leukaemia. Kansenshogaku Zasshi 1987; 61: 362-367
26. Walling DM, McGraw DJ, Merz WG, Karp JE, Hutchins GM. Disseminated infection with Trichosporon beigelii. Rev Infect Dis 1987; 9: 13-19
27. Lowenthal RM, Atkinson K, Challis DR, Tucker RG, Biggs JC. Invasive Trichosporon cutaneum infection: an increasing problem in immunosuppressed patients. Bone Marrow Transplant 1987; 2: 321-327
28. Ito T, Ishikawa Y, Fujii R, Hattori T, Konno M, Kawakami S, Kosakai M. Disseminated Trichosporon capitatum infection in a patient with acute leukaemia. Cancer 1988; 61: 585-588
29. Siegert W, Henze G, Wagner J et al. Invasive Trichosporon cutaneum (beigelii) infection in a patient with relapsed acute myeloid leukaemia undergoing bone marrow transplantation. Transplantation 1988; 46: 151-153
30. Mochizuki T, Sugiura H, Watanabe S, Takada M, Hodohara K, Kushima R..A case of disseminated Trichosporonosis: A case report and immunohistochemical identification of fungal elements. J Med Vet Mycol 1988; 26: 343-349
31. Fukayama M, Inamatsu T, Mori M, Miwa A. Disseminated Trichosporon beigelii infection in a patient with acute myelogenous leukaemia. Kansenshogaku Zasshi 1988; 62: 734-738
32. Greenberg RG. Postoperative Trichosporon beigelii soft tissue infection. J Dermatol Surg Oncol 1989; 15: 432-434
33. Parsonnet J. Postoperative Trichosporon beigelii peritonitis. South Med J 1989; 82: 1062-1063
34. Payne AL, Teall AJ. Trichosporon beigelii infection in an immunocompromised host. Mycoses 1989; 32: 183-186
35. Santhosh-Kumar CR, al-Hedaithy S, el-Saghir NS, Ajarim DS. Cavitating pneumonia due to Trichosporon beigelii in a patient with acute myeloid leukaemia. J Infect 1989; 19: 65-68
36. Sarmont I, Vergauwen B, Marcelis L, Verbist L, Verhoef J, Boogaerts M. First report of chronic meningitis caused by Trichosporon beigelli. Eur J Clin Microbiol Infect Dis 1990; 9: 226-229
37. Ogata K, Tanabe Y, Iwakiri K, Ito T, Yamada T, Dan K, Nomura T. Two cases of disseminated Trichosporon beigelii infection treated with combination antifungal therapy. Cancer 1990; 65: 2793-2795
38. Herbrecht R, Liu KL, Koenig H et al. Trichosporon capitatum septicemia in immunosuppressed patients. Pathol Biol (Paris) 1990; 38: 585-588
39. Walsh TJ, Melcher GP, Rinaldi MG et al. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B J Clin Microbiol 1990; 28: 1616-1622
40. Liu KL, Herbrecht R, Bergerat JP, Koenig H, Waller J, Oberling F. Disseminated Trichosporon capitatum infection in a patient with acute leukaemia undergoing bone marrow transplantation. Bone Marrow Transplant. 1990; 6: 219-221
41. Ashpole RD, Jacobson K, King AT, Holmes AE. Cysto-peritoneal shunt infection with Trichosporon beigelii. Br J Neurosurg 1991; 5: 515-517
42. Alballaa S, Bryce EA, Roberts FJ, Sekhon A. Fatal Trichosporonosis is not related to tolerance to amphotericin B. Mycoses: 1991; 34: 317-318
43. Girmenia C, Micozzi A, Venditti M, Meloni G, Iori AP, Bastianello S, Martino, P. Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur J Clin Microbiol Infect Dis 1991; 10: 752-756
44. Yamauchi K, Sato T. Trichosporon beigelii pneumonitis following busulphan-induced leucopenia. Eur Respir J 1992; 5: 594-597
45. McWhinney PH, Madgwick JC, Hoffbrand AV, Bhamra A, Kibbler CC. Successful surgical management of septic arthritis due to Trichosporon beigelii in a patient with acute myeloid leukaemia. Scand J Infect Dis 1992; 24: 245-247
46. Qadri SM, Ellis ME. Localized pulmonary disease due to Trichosporon beigelii J Natl Med Assoc 1992; 84: 449-452
47. Anaissie E, Gokaslan A, Hachem R et al. Azole therapy for trichosporonosis: Clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis 1992; 15: 781-787
48. Syčová-Milá Z, Šufliarsky J, Trupl J, Jasenská Z, Blahva Krčméry V Jr. Catheter associated septicaemia due to Trichosporon capitatum. J Hosp Infect 1992; 22: 257-258
49. Shigehara K, Takahashi K, Tsunematsu K, Koba H, Katoh S, Asakawa M, Suzuki A. case of Trichosporon pullulans infection of the lung with adult T-cell leukaemia. Jpn J Med 1991; 30: 135-137
50. Vasta S, Menozzi M, Seime R et al. Central catheter infection by Trichosporon beigelii after autologous bloodstem cell transplantation. A case report and review of the literature. Haematologica 1993; 78: 64-67
51. Nahass GT, Rosenberg SP, Leonardi CL, Penneys NS. Disseminated infection with Trichosporon beigelii. Report of a case and review of the cutaneous and histologic manifestations. Arch Dermatol 1993; 129: 1020-1023
52. Krčméry V Jr, Trupl J. Trichosporon fungaemia in cancer patients: report of 12 cases. Acta Chemoth 1997; 4: 33-37
53. Herbrecht R, Liu KL, Koenig H, Waller J, Dufour P, Marcellin L, Maloisel F. Trichosporon capitatum septicemia. Apropos of 5 cases. Agressologie 1992; 33: 96-98
54. Walsh TJ, Melcher GP, Lee JW, Pizzo PA. Infections due to Trichosporon species: New concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol 1993; 5: 79-113
55. Nasu K, Akizuki S, Yoshiyama K, Kikuchi H, Higuchi Y, Yamamoto S. Disseminated Trichosporon infection. A case report and immunohistochemical study. Arch Pathol Lab Med 1994; 118: 191-194
56. Morimoto S, Shimazaki C, Goto H et al. Trichosporon cutaneum fungemia in patients with acute myeloblastic leukaemia and measurement of serum D-arabinitol, Candida antigen (Cand-tec), and beta-D-glucan. Ann Hematol 1994; 68: 159-161
57. Tashiro T, Nagai H, Kamberi P, Goto Y, Naum S, Kikuchi H, Akizuki S. Disseminated Trichosporon beigelii infection in patients with malignant disease. Eur J Clin Microbiol Inf Dis 1994; 13: 218-224
58. Naum S, Petersson SR, Weinbaum P, Rosenfield CS. Long term survival after allogeneic bone marrow transplantation complicated by trichosporonosis. South Med J 1994; 87: 286-287
59. Sanz MA, Lopez F, Martinez M, Sanz G, Martinez J, Martinez G, Gobernado M. Blastoschizomyces capitatus fungaemia in leukaemia patients. Support Care Cane 1996; 4: 291-293
60. Venditti M, Posteraro B, Morace G, Martino P. In vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus. J Chemoth 1991; 3: 13-15
61. Keay S, Denning DW, Stevens D. Endocarditis due to Trichosporon beigelii: In vitro susceptibility of isolates and review. Rev In J Dis 1991; 13: 383-386
62. Krčméry V. Emerging fungal infections in cancer patients. J Hosp Inf 1997; 32: 11-722
63. Kiehn TE, Armstrong D. Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices. Eur J Clin Microb Infect Dis 1990; 9: 869-872
64. Anaissie E, Bodey GP, Kantarjian H, Rolston K, Vartivarian S. New spectrum of fungal infections in patients with cancer. Rev Infect Dis 1989; 11: 369-378
65. Leeber DA, Scher I. Rhodotorula fungemia presenting as "endotoxic" shock. Arch Intern Med 1969; 123: 78-81
66. Louria DB, Blevins A, Armstrong D, Burdich R, Lieberman P. Fungemia caused by "nonpathogenic" yeasts. Arch Intern Med 1967; 119: 247-252
67. Louria DB, Greenberg SM, Molander DW. Fungemia caused by certain nonpathogenic strains of the family Cryptococcaceae. N Engl J Med 1960; 263: 1281-1284
68. Pien FD, Thompson RL, Deye D, Roberts GD. Rhodotorula septicemia. Two cases and a review of the literature. Mayo Clin Proc 1980; 55: 258-260
69. Shelburn PF, Carey RJ. Rhodotorula fungemia complicating staphylococcal endocarditis. JAMA 1962; 180: 38-42
70. Hutter RV, Collins HS. The occurrence of opportunistic fungus infections in a cancer hospital. Lab Invest 1962; 11: 1035-1045
71. Marinová I, Sabadošová V, Krčméry V Jr. Rhodotorula rubra fungemia in 12-years boy. Chemother 1994; 40: 243-244
72. Klein AS, Tortola GT, Malowitz R, Greene WH. Hansenula anomala: a new fungal pathogen. Arch Intern Med 1988; 148: 1210
73. Haron E, Unisia E, Dumphy F, McCredie K, Fainstain V. Hansenula anomala fungemia. Rev Infect Dis 1988; 10: 1182
74. Lopez F, Martin G, Paz ML, Sanz MA. Hansenula anomala infection in acute leukaemia. Enferm Infec Microbiol Clin 1990; 8: 363
75. Hirasaki S, Ijichi T, Fujita H, Araki S, Gotoh H, Nakagawa M. Fungemia caused by Hansenula anomala: successful treatment with fluconazole. Intern Med 1992; 31: 622
76. Kunová A, Špánik S, Kollár T, Krčméry V, Jr. Breakthrough fungaemia due to Hansenula anomala in a leukaemia patient successfully treated with amphotericin B J Chemoth 1996; 8: 85-86
77. Cimolai N, Gill MJ, Church D. Saccharomyces cerevisiae fungemia: case report and review of the literature. Diagn Microbiol Infect Dis 1987; 8: 113-117
78. Dougherty SH, Simmons RL. Postoperative peritonitis caused by Saccharomyces cerevisiae. Arch Surg 1982; 117: 248-249
79. Eschete ML, West BC. Saccharomyces cerevisiae septicemia. Arch Intern Med 1980; 140: 1539
80. Gimeno CJ, Ljungdahl PO, Styles CA, Fink GR. Unipolar cell divisions in the yeast Saccharomyces cerevisiae lead to filamentous growth: regulation by starvation and RAS. Cell 1992; 68: 1077-1090
81. Manzella JP, Shaffer S, Agarwal N, Kellogg JA. Saccharomyces cerevisiae fungemia in a multiply traumatized patient, J Trauma 1989; 29: 129-130
82. Smith DL. Brewers yeast as a cause of Infection. Clin Inf Dis 1996; 22: 201
83. Aucott JN, Fayen J, Grossnicklas H, Morrissey A, Lederman MM, Salata RA. Invasive infection with Saccharomyces cerevisiae: report of three cases and review. Rev Infect Dis 1990; 12: 406-411
84. Oriol A, Ribera JM, Arnal J, Milla F, Batlle M, Feliu E. Saccharomyces cerevisiae septicemia in a patient with myelodysplastic syndrome. Am J Hematol 1993; 43: 325-326
85. Chertow GM, Marcantonio E-R, Wells RG. Saccharomyces cerevisiae empyema in a patient with esophago-pleural fistula complicating variceal sclerotherapy. Chest 1991; 99: 1518-1519
86. Snyder S. Peritonitis due to Saccharomyces cerevisiae in a patient on CAPD (letter). Perit Dial Int 1992; 12: 77-78
87. Bonnay S, Darchis JP, Veyssier P. Saccharomyces cerevisiae septicaemia in a cancer patient. Médecine et Maladies Infectieuses 1991; 21: 73-74
88. Doyle MG, Pickering LK, O'Brien N, Hoots K. Saccharomyces cerevisiae infection in a patient with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1990; 9: 850-851
89. Sobel JD, Vazquez J, Lynch M, Meriwether C, Zervos MJ. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy. Clin Infect Dis 1993; 16: 93-94
90. Eng R, Drehmel R, Smith SM, Goldstein E. Saccharomyces cerevisiae infections in man. Sabourandia 1984; 20: 403-407
91. Mydlik M, Szovenyiová Z. Saccharomyces spp. peritonitis during CAPD. Perit Dial Int 1996; 16: 184-188
92. Sereville E, Ajana F, Girard Y, Bourez JM, Alfandar IS, Chidiac Ch, Mouton Y. Bilateral obstruction due to S. cerevisiae fungus balls. Clin Infect Dis 1996; 23: 636-637
93. Wingard JR. Importance of Candida species other than Candida albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115-125
94. Atsner J, Schimpff SC, Sutherland JC, Young VM, Wiernik PH. Torulopsis glabrata infections in patients with cancer: increasing incidence and relationship to colonization. Am J Med 1976; 61: 23-28
95. Krčméry S, Masár O, Krčméry V, Jr. Torulopsis glabrata fungaemia in a pregnant women successfully treated with fluconazole. J Chemother 1996; 8: 89-90
96. Corbella X, Carratala J, Castells M, Berlanga B. Fluconazole treatment in Torulopsis glabrata upper urinary tract infection causing ureteral obstruction. J Urol 1991; 147: 1116-1117
97. Thomas MG, Ellis-Pegler B. Fluconazole treatment of Candida glabrata peritonitis. J Antimicrob Chemother 1989; 24: 94-95
98. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 1993; 37: 1847-1849
99. Van't Wout J. Fluconazole treatment of Candida infections caused by non-albicans Candida spp. Eur J Clin Microbial Infect Dis 1996; 15: 238-242
100. Kunová A, Trupl J, Špánik S, Sufliarsky J, Krčméry V Jr. Candida glabrata and Candida krusei in a national cancer institute in 1989-1993, no association with the use of fluconazole. Chemotherapy 1995; 42: 82-88
101. Kridl J, Danišovičová A, Krčméry V jr. Torulopsis glabrata pyelonephritis and fungaemia successfully treated with fluconazole. Clin Infect Dis 1994; 18: 96.